Penelope M. Webb
QIMR Berghofer Medical Research Institute
EpidemiologyCancerInternal medicineGenotypeOncologyCase-control studySerous fluidSingle-nucleotide polymorphismOdds ratioEndometrial cancerBody mass indexOvarian cancerPopulationGynecologyConfidence intervalRisk factorMedicineCohortBiologyGastroenterology
436Publications
80H-index
16.1kCitations
Publications 431
Newest
#1Katharine Brieger (UM: University of Michigan)H-Index: 3
#2Minh Tung Phung (UM: University of Michigan)H-Index: 1
Last. Celeste Leigh Pearce (UM: University of Michigan)H-Index: 50
view all 48 authors...
Background There is suggestive evidence that inflammation is related to ovarian cancer survival. However, more research is needed to identify inflammation-related factors that are associated with ovarian cancer survival and to determine their combined effects. Methods This analysis used pooled data on 8,147 women with invasive epithelial ovarian cancer from the Ovarian Cancer Association Consortium. Pre-diagnosis inflammatory-related exposures of interest included alcohol use, aspirin use, other...
Source
#1Lilah Khoja (UM: University of Michigan)H-Index: 2
#2Rachel Palmieri Weber (Duke University)H-Index: 26
Last. Alice W. Lee (CSUF: California State University, Fullerton)H-Index: 11
view all 30 authors...
Objective null To evaluate the association between hysterectomy and ovarian cancer, and to understand how hormone therapy (HT) use and endometriosis affect this association. null Methods null We conducted a pooled analysis of self-reported data from 11 case-control studies in the Ovarian Cancer Association Consortium (OCAC). Women with (n = 5350) and without ovarian cancer (n = 7544) who never used HT or exclusively used either estrogen-only therapy (ET) or estrogen+progestin therapy (EPT) were ...
Source
#1Renee N. Carey (Curtin University)H-Index: 13
#2David C. Whiteman (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 88
Last. Lin Fritschi (Curtin University)H-Index: 69
view all 7 authors...
Abstract null null Background null Many cancers are caused by exposure to lifestyle, environmental, and occupational factors. Earlier studies have estimated the number of cancers occurring in a single year which are attributable to past exposures to these factors. However, there is now increasing appreciation that estimates of the future burden of cancer may be more useful for policy and prevention. We aimed to calculate the future number of cancers expected to arise as a result of exposure to 2...
Source
#1Paul A. CohenH-Index: 20
#2Penelope M. Webb (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 80
Last. Rachel Campbell (USYD: University of Sydney)H-Index: 10
view all 30 authors...
BACKGROUND: Physical symptoms, anxiety, depression, fear of recurrence, sexual dysfunction, and social withdrawal are common in women after treatment for ovarian cancer. Most patients would like and need help dealing with these symptoms. The traditional model of follow-up care is unstructured and largely focused on diagnosing recurrent disease, and most oncologists lack skills to identify and manage psychosocial issues. No high quality prospective clinical trials have been conducted to determine...
Source
#1Hai Pham (UQ: University of Queensland)H-Index: 4
#2Mary Waterhouse (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 12
Last. Michael Kimlin (University of Melbourne)
view all 17 authors...
Source
#1Rachel Campbell (USYD: University of Sydney)H-Index: 10
#2Madeleine King (USYD: University of Sydney)H-Index: 69
Last. Penelope M. Webb (UQ: University of Queensland)H-Index: 80
view all 6 authors...
Abstract null null Objective null The Measure of Ovarian Symptoms and Treatment (MOST-T35) is a patient-reported symptom index, developed and validated in the context of palliative chemotherapy for recurrent ovarian cancer (OC). We aimed to develop and validate a version suitable for surveillance of symptoms following first-line treatment for OC to support clinical follow-up. null null null Methods null In a prospective study of women following completion of first-line chemotherapy for OC, patie...
Source
#1Nina Renhua Na (QIMR: QIMR Berghofer Medical Research Institute)
#2Susan J. Jordan (UQ: University of Queensland)H-Index: 31
Last. Penelope M. Webb (UQ: University of Queensland)H-Index: 80
view all 4 authors...
Source
#1Karen M. Tuesley (UQ: University of Queensland)H-Index: 2
#2Penelope M. Webb (UQ: University of Queensland)H-Index: 80
Last. Susan J. Jordan (UQ: University of Queensland)H-Index: 31
view all 10 authors...
Source
#1Azam Majidi (UQ: University of Queensland)H-Index: 8
#2Renhua Na (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 10
Last. Penelope M. Webb (UQ: University of Queensland)H-Index: 80
view all 5 authors...
Source
#1Mary Waterhouse (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 12
#2Emma Sanguineti (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 1
Last. Michael G. Kimlin (QUT: Queensland University of Technology)H-Index: 37
view all 17 authors...
BACKGROUND: Falls cause considerable morbidity and mortality in older people. It is unclear how vitamin D supplementation affects falls risk, particularly when taken at high doses. We sought to determine whether monthly high-dose vitamin D supplementation reduces risk and incidence of falls. METHODS: We used data from the randomized, double-blind, placebo-controlled D-Health Trial conducted in Australia. Between February 2014 and May 2015, 21 315 participants aged 60-84 years were randomized (1:...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.